These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17302907)

  • 1. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
    Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
    Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of donor-derived thymic epithelial cells in [B6-->MRL/lpr] mice after allogeneic intra-bone marrow-bone marrow transplantation (IBM-BMT).
    Takaki T; Hosaka N; Miyake T; Cui W; Nishida T; Inaba M; Ikehara S
    J Autoimmun; 2008 Dec; 31(4):408-15. PubMed ID: 19022623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
    Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
    J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation.
    Kushida T; Inaba M; Takeuchi K; Sugiura K; Ogawa R; Ikehara S
    Blood; 2000 Mar; 95(5):1862-8. PubMed ID: 10688849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
    Lee S; Iwai H; Sugiura K; Takeuchi K; Kushida T; Tomoda K; Inaba M; Yamashita T; Ikehara S
    Bone Marrow Transplant; 2000 Oct; 26(8):887-92. PubMed ID: 11081390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice.
    Kushida T; Inaba M; Hisha H; Ichioka N; Esumi T; Ogawa R; Iida H; Ikehara S
    Blood; 2001 May; 97(10):3292-9. PubMed ID: 11342461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
    Nishida T; Hosaka N; Takaki T; Miyake T; Cui W; Inaba M; Kinoshita H; Matsuda T; Ikehara S
    Bone Marrow Transplant; 2009 Jun; 43(11):829-37. PubMed ID: 19079314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.
    Ishida T; Inaba M; Hisha H; Sugiura K; Adachi Y; Nagata N; Ogawa R; Good RA; Ikehara S
    J Immunol; 1994 Mar; 152(6):3119-27. PubMed ID: 8144907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
    Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
    J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies for BMT, organ transplantation, and regeneration therapy.
    Ikehara S
    Hematology; 2003 Apr; 8(2):77-81. PubMed ID: 12745656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyses of acute graft-versus-host-like reaction in [MRL/lpr----MRL/+] chimeric mice using MRL/lpr-Thy-1. 1 congenic mice.
    Nakagawa T; Nagata N; Hosaka N; Inaba M; Yasumizu R; Ogawa R; Ikehara S
    Cell Immunol; 1991 Oct; 137(1):189-99. PubMed ID: 1679378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of tolerance induction using triple chimeric mice: major histocompatibility complex-disparate thymus, hemopoietic cells, and microenvironment.
    Cui W; Hosaka N; Miyake T; Wang X; Guo K; Cui Y; Li Q; Song C; Feng W; Li Q; Takaki T; Nishida T; Inaba M; Ikehara S
    Transplantation; 2008 Apr; 85(8):1151-8. PubMed ID: 18431236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages.
    Glaser RM; Marshak-Rothstein A
    Eur J Immunol; 1990 Sep; 20(9):1917-25. PubMed ID: 2209698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice.
    Takeuchi K; Inaba M; Miyashima S; Ogawa R; Ikehara S
    Blood; 1998 Jun; 91(12):4616-23. PubMed ID: 9616158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies for allogeneic BMT.
    Ikehara S
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S73-5. PubMed ID: 12931248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of origin of synovial cells and repairing mechanisms of arthritis by allogeneic bone marrow transplantation.
    Kitagawa H; Toki J; Inaba M; Sugiura K; Ogawa R; Ikehara S
    Immunobiology; 1993 Jun; 188(1-2):99-112. PubMed ID: 8406562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation: a new strategy for intractable diseases.
    Ikehara S
    Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation.
    Ikehara S; Yasumizu R; Inaba M; Izui S; Hayakawa K; Sekita K; Toki J; Sugiura K; Iwai H; Nakamura T
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3306-10. PubMed ID: 2654943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crucial role of donor-derived stromal cells in successful treatment for intractable autoimmune diseases in mrl/lpr mice by bmt via portal vein.
    Kushida T; Inaba M; Hisha H; Ichioka N; Esumi T; Ogawa R; Iida H; Ikehara S
    Stem Cells; 2001; 19(3):226-35. PubMed ID: 11359948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of lpr-GVHD by adoptive transfer experiments using MRL/lpr-Thy-1.1 congenic mice.
    Hosaka N; Nagata N; Nakagawa T; Miyashima S; Yasumizu R; Ikehara S
    Autoimmunity; 1994; 17(3):217-24. PubMed ID: 7948606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.